Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04910139 · ClinicalTrials.gov registry record · NA
A User Study of the Soniflow System for Nasal Congestion Relief
A NA study, sponsored by Third Wave Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04910139 is a NA study that has completed, run by Third Wave Therapeutics. The registered enrollment target is 50 participants.
The verdict
NCT04910139, a NA study, has completed, sponsored by Third Wave Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The Soniflow System consists of an acoustic vibrational headband paired with a Smartphone App to provide rapid relief of nasal congestion.
Interventions
- DEVICE Soniflow System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2020-07-15 |
| Est. Completion | 2021-01-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04910139
The ClinicalTrials.gov registry entry for NCT04910139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Third Wave Therapeutics, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soniflow System is the first listed.
NCT04910139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04910139 about?
NCT04910139 is a clinical study titled "A User Study of the Soniflow System for Nasal Congestion Relief". The Soniflow System consists of an acoustic vibrational headband paired with a Smartphone App to provide rapid relief of nasal congestion.
What is the current status of trial NCT04910139?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-07-15. Estimated completion is 2021-01-26.
What interventions are being tested in trial NCT04910139?
The interventions under investigation include: Soniflow System (DEVICE).
Who is sponsoring clinical trial NCT04910139?
This trial is sponsored by Third Wave Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.